DrugChatter: When was apotex s ruxolitinib anda filed?
When Was Apotex's Ruxolitinib ANDA Filed?IntroductionRuxolitinib, a Janus kinase (JAK) inhibitor, is a medication used to treat patients with myelofibrosis, a type of bone marrow cancer. Apotex, a Canadian pharmaceutical company, has been working …
DrugChatter: When was apotex s ruxolitinib anda filed? Read Post »